Dr. Paul Yien Kwo, Dr.
Claim this profileStanford Medicine Outpatient Center
Studies Hepatitis
Studies Hepatitis Delta
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Paul Yien Kwo, Dr.
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Paul Yien Kwo, Dr. has experience with
- Peginterferon Lambda-1a
Breakdown of trials Paul Yien Kwo, Dr. has run
Hepatitis Delta
Hepatitis A
Hepatitis D
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Yien Kwo, Dr. specialize in?
Paul Yien Kwo, Dr. focuses on Hepatitis and Hepatitis Delta. In particular, much of their work with Hepatitis has involved treating patients, or patients who are undergoing treatment.
Is Paul Yien Kwo, Dr. currently recruiting for clinical trials?
No, Paul Yien Kwo, Dr. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Paul Yien Kwo, Dr. has studied deeply?
Yes, Paul Yien Kwo, Dr. has studied treatments such as Peginterferon Lambda-1a.
What is the best way to schedule an appointment with Paul Yien Kwo, Dr.?
Apply for one of the trials that Paul Yien Kwo, Dr. is conducting.
What is the office address of Paul Yien Kwo, Dr.?
The office of Paul Yien Kwo, Dr. is located at: Stanford Medicine Outpatient Center, Redwood City, California 94063 United States. This is the address for their practice at the Stanford Medicine Outpatient Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.